| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |